chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I gained about 30lbs went from 155- 185 (weight increased about 5-10lbs every 2 weeks) body muscle mass grew? shoulders, back chest, quads etc grew, do have fat but it looks like I bulked up when I haven't worked out since COVID. Prior COVID, I went to martial arts 4 times a week and went to the gym 4-5 times a week still. My awareness was not good, hand dexterity was not as high, concentrating was not easy for long, high blood pressure, pre diabetic now,  fatty liver, gallbladder stones/sludge, have high wbc count, rbc count high, high alt/ast range is 44-88-116-222, skin sensititivty, could only stay awake for 6 hours at a time.  BTold to introduce coffee to help liver/ keep taking baby aspirin/ put back on Dexilant 60mg. When working out, I go to sleep within an hour of running 1 mile,  weight lifting gets me extremely tired now, now its not as bad, can work out longer.  In may, all my allergies disappeared, now they are back but in first month I was no longer allergic to fruits. This is new and started in June, pimples on skull and ears, voice is normal now, may have grown taller, leg shins hurt when touched. Skin still very sensitive, awake longer now  but when I work out I still get tired where I have to stop, sit, or nap.
Soreness at injection sight, soreness in joints and muscles, headache, chills, fever of over 100°F, hot sweats, dizziness.
Shortly after flu shot was administered patient slumped down in chair, passed out, and slid down to the floor.  A customer called 911. The patient regained consciousness very quickly, seconds after passing out.  He stood up, but his father and the pharmacist had him sit down.  He threw up shortly after.  He was given bottle water.  After a few minutes, the ambulance showed up and the patient was evaluated.  His blood pressure was taken.  It was learned that that patient had passed out after a shot before, and he had not eaten anything since the night before.  He left the store with his father, and declined being taken to the hospital.
April 10 started having irregular high heart rhythm. Was then diagnosed with SVT. Had never had a heart condition before the vaccine. Now I have a cardiologist I need an echocardiogram and a cardiac ablation.
-Sharp pain in my head when sneezing or coughing, still today 10/10/2021 -Oxygen levels dropped to 92% 2 days after shot.
lmproperly stored PROQUAD administered to a patient.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.   On 25-JUL-2021, a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) lot # T016990, expiration date 11-NOV-2021 experienced the temperature excursion of 6 to 14 degrees Fahrenheit (7.3F) for 37 minutes. On 31-AUG-2021, the patient was vaccinated with the improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # T016990, 0.5 mL x 1 dose, subcutaneously (SQ) (formulation and anatomical location were not reported) for prophylaxis (product storage error). No product quality complain reported. On 14-SEP-2021, the vaccine experienced temperature excursion of 6 to 14 (9.9F) or 2 hours and 11 minutes. On 15-SEP-2021, the vaccine experienced temperature excursion of 6 to 14 (6.6F) for 59 minutes.
limited vomiting for 12 hrs; profuse diarrhea & cramps x 7 days; no treatment x/Pepto Bismul by pt;
Getting infected with COVID; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Getting infected with COVID) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Getting infected with COVID). At the time of the report, COVID-19 (Getting infected with COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medication were reported. The reporter states that people who have received the COVID-19 vaccine in her area are getting infected with COVID-19.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. In November 2017, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced shingles and product supply issue. On an unknown date, the outcome of the shingles and product supply issue were unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had 1st dose of SHINGRIX dose and did not find availability for the 2nd dose of SHINGRIX with no hope in sight from any location, which led to product supply issue. In November 2018, the patient had the original vaccine and she then got Shingles last year after receiving the 1st part of the SHINGRIX then she had another but in November. The patient received first shot November of last year and then got shingles. The patient stated, she had tried everything, her doctor and pharmacies but they did not have any more information than she did. The patient asked If the company begins to dispatch the shipment on the reporting date, then how long could the shipment for and asked if the ship the needed amount. Especially for the 2nd dose which only had 6 months after the 1st dose of SHINGRIX.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Feb2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "RA" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing); "controlled high cholesterol" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Codeine, reaction(s): "known allergies: codeine". The following information was reported: DISEASE RECURRENCE (medically significant) with onset 04Sep2022, outcome "not recovered", described as "tested negative for 5 days using a home test starting 27Aug2022/ took a home test twice, both positive"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (27Aug2022) Negative, notes: I tested negative for 5 days using a home test starting 27Aug; (28Aug2022) Negative, notes: I tested negative for 5 days using a home test starting 27Aug; (29Aug2022) Negative, notes: I tested negative for 5 days using a home test starting 27Aug; (30Aug2022) Negative, notes: I tested negative for 5 days using a home test starting 27Aug; (31Aug2022) Negative, notes: I tested negative for 5 days using a home test starting 27Aug; (04Sep2022) Positive, notes: Took a home test twice, both positive; (04Sep2022) Positive, notes: Took a home test twice, both positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: Paxlovid was given as treatment for covid-19 starting on 24Aug2022 till 28Aug2022. Other medication were given in 2 weeks. It was reported that only adverse event was that the patient tested negative for 5 days using a home test starting 27Aug. Started feeling a little sick at her stomach on 04Sep. Took a home test twice, both positive. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Dizziness, Arthralgia, Fever, NauseaVomiting, chills, fever, fatigue, weakness Narrative:  Other Relevant History:
1/6 Fatigue, diffuse slight buzzing  skin arms, legs torso with mild nausea /anorexia, frontal headache  1/7 Severe fatigue but Insomnia. Difficulty concentrating. Diffuse myalgias/arthralgias in every muscle and joint, large & small, even fingers & toes. Nausea, anorexia, vomiting. Hot and cold chills, temp 96.7 pilo-erection.  Severe mid-line low back pain L1-L2. Severe headache across low-forehead (just above eyebrows) to bilat temples to bilat cheek bones to maxillary incisors and canine teeth. Severe bilat eye pain (hurt to move or to touch eyes, but no photophobia or visual changes). Red-rimmed eyes. Facial pallor. Tender swollen left deltoid (left arm circumf 1" > Rt arm). Tender Left Axillary adenopathy.  1/8/2021 - 1/10/2021 Sx remained severe 1/9/2021 - 1/17/2021 Gradual improvement in Sx w/decreased but persistent muscle/joint pain, mid-line low back pain, severe fatigue,  anorexia, difficulty concentrating, anoexia and occasional vomiting.  1/18 - 1/22 Recurrent nausea w/ inc vomiting, increasing fatigue, increasing myalgias/arthragias, recurrent frontal/facial pain and eye pain, marked increase in mid-line low back pain, recurrent facial pallor and re-rimmed eyes.
70yo M NIDDM 2 days s/p Moderna vaccine to R deltoid, developed symptoms of ulnar neuropathy (Weakness to R 4th/5th digits, paresthesias to the area).  Evaluation including labs performed but no evidence this is a cervical spine disease, patient has longstanding peripheral neuropathy of toes but this is different and involves weakness.
Patient required hospitalization due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 02/19/21. Patient was hospitalized from 08/13/21 - 08/31/21. Below is copied from patients discharge (death) summary:   Hospital Course: Patient is a vaccinated 75 y.o. male with a pmhx of HTN, DM, CAD s/p PCI (10 yrs ago), CKD3 and breast cancer s/p lumpectomy and CT who presented to ED on 8/13/21 c/o SOB in setting of known COVID-19 infection. Patient recieved both doses of his vaccine (2nd dose 2/2021).  Patient was admitted to hospitalist service for acute hypoxic respiratory failure in setting of COVID-19. Throughout course of stay, had increasing oxygenation requirements (requiring FFCPAP after found to have removed mask from face) with pulse ox O2 sats reportedly in 20's, lethargy, and new onset tremor. On pulmonology's evaluation at bedside, patient was A&Ox2 (person/place, thinks year is 2001). Not hypoglycemic on accucheck. Difficult to obtain hx as patient with AMS however shakes head yes when asked if he feels SOB.  Admitted to ICU on 18Aug, now intubated and sedated.  Bronchoscopy performed at bedside, which was unrevealing.  Did not show any mucous plugging. Received solumedrol and lipitor. Toci not given due to depleted supplies.  Episodes of hypoglycemia, NPH 35u TID d/c. S/p D5W drip. Continue with SSI. Oligouric AKI on CKD, requiring CRRT. Nephrology on board. New onset A-fib with RVR, now rate controlled. S/p amiodarone drip & metoprolol. Increasing leukocytosis. Continue Vanc/Aztreonam/Flagyl and empiric Caspo, follow cultures. Episodes of coffee ground emesis. Hgb downtrended. Recevied 1 unit of pRBC. Hgb stable. On Levophed. Continue proning protocol. CRRT better when placed in left position. Keep net even. Wean off Levo as tolerated, start midodrine 10mg tid. DC empiric Abx given negative cultures. Palliative care for goals of care. Shock state of unclear etiology at this time. EV1000 hemodynamics to help guide management. Currently on 40 of levophed and vasopressin. Poor oxygenation. Prone ventilation discontinued. DC'd empiric Abx given negative cultures. Spoke to patient's wife and she wants patient to be DNR with no escalation of care given his overall poor prognosis. Plan to compassionately wean. Confirmed DNR. No further escalation of care.     Death Note  I was called to the room of patient to pronounce that patient had died. Patient was laying motionless and unresponsive to verbal/tactile stimuli. Pupils where fixed and dilated. There were no spontaneous breath sounds. Peripheral pulses were absent. No heartbeat was heard during auscultation. Family was made aware.  Condolences offered. Chaplain and postmortem services offered. Pt was DNR code. Time of death was 1724, confirmed and witnessed by Nurse
morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,; bruise at injection site; swollen at the injection site; headache; itchiness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache), INJECTION SITE PRURITUS (itchiness at the injection site), RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,) and CONTUSION (bruise at injection site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Blood disorder (Von-Willebrand.) and Drug allergy (Tylenol allergy). Concomitant products included VITAMINS NOS for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Feb-2021, the patient experienced INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache) and INJECTION SITE PRURITUS (itchiness at the injection site). On 28-Feb-2021, the patient experienced CONTUSION (bruise at injection site). On 01-Mar-2021, the patient experienced RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, INJECTION SITE SWELLING (swollen at the injection site), HEADACHE (headache), INJECTION SITE PRURITUS (itchiness at the injection site), RASH (morning appeared a rush all over the body, mostly on the trunk , growing areas and knees ,) and CONTUSION (bruise at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reported that patient called her doctor and sent her to an allergist. No other treatment details provided.
no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 18-NOV-2022, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This is one of several reports received from same reporter. ; Sender's Comments:  US-009507513-2304USA002221:
Shoulder Injury Related, tiredness, headache, muscle and bones pain, chills, joint pain,  fever, feeling unwell, back pain, pain in the lower abdomen as with menstruation, no energy
Varivax given on 10/31/1995 and 1 week later, developed chickenpox. Now with chickenpox again.
p/vax pt devel three erythematous lesions w/vesicular centers on rt  hand, rt leg & forehead;pt sought unspecified medical attention;
PATIENT STATES APPROXIMATELY 10 HOURS AFTER RECEIVING THE VACCINE, HE EXPERIENCED DIZZINESS AND TIREDNESS, THEN 2 HOURS LATER HE EXPERIENCED TACHYCARDIA - PATIENT STATES HE WAS ADMITTED TO HOSPITAL ICU BASED ON HIS HEART RATE AND WAS DISCHARGED 2 DAYS LATER.
Dizziness, Headache, Myalgia, Fever, Diarrhea & NauseaVomiting Narrative:
approx 2 hrs p/vax pt had shrill, uncontrollable crying lasting 1 1/2-2 hrs @ a time until 8AM on 14FEB95; APAP given w/some relief but not for long; pediatrician advised eliminating P from further DTP;
Urticaria began on leg opposite to injection site. No wheezing. Treatment: Beandryl.
she had a positive COVID test on 27Jan2022 from Lab; she had a positive COVID test on 27Jan2022 from Lab; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP).  A 51-year-old female patient received BNT162b2 (BNT162B2), on 17Feb2021 as dose 2, single (Lot number: EN6200) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 27Jan2022, outcome "unknown" and all described as "she had a positive COVID test on 27Jan2022 from Lab". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Jan2022) Positive.  Clinical course: They were contacted about this case as the bivalent was captured as suspect when the date of event was Feb2022 which was prior to the bivalent being available. Further the lot number refers to the monovalent (PBS-purple cap). Below was the information from VAERS for the case. Also note the vaccine given on 17Feb2021 was the second dose-therefore the patient had received dose one of an unspecified COVID vaccine. Also, there was present as the patient tested positive on 27Jan2022-this information does not seem to be captured anywhere. 51-year female patient. Date died was 05Feb2022. Patient passed away at home, she had a positive COVID test on 27Jan2022 from lab.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. In approximately May 2013, the patient was vaccinated with the first 0.5 ml dose of GARDASIL (lot # not reported) intramuscularly. On approximately 12-MAR-2014, the patient received the second 0.5 ml dose of GARDASIL (lot # not reported) intramuscularly and on 21-MAY-2014, 10 weeks after second dose, the patient received the third 0.5 ml dose of GARDASIL (lot # not reported) intramuscularly. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Patient experienced fever, chills, malaise, and fatigue starting the day after the vaccination was given. Symptoms resolved a day later.
Information has been received from a physician concerning a 10 year old (also reported as 9 year old) male who on an unspecified date was vaccinated with a dose of MMR II (route, site, dose and lot number not reported). On 30-DEC-2009, the patient experienced mumps (date diagnosed was reported as 01-JAN-2010). The patient had a temp of 102.7 degrees F. The outcome for mumps was not reported. No further information is available.
Hours after 2 nd dose of Covid vaccine extremely loud constant ringing in my ears began louder than when the first dose was given. Hearing  is muffled, muted and periodically episodes of deafness lasting 10-35 seconds keep happening. My right side of neck and head is swollen and painful to touch. These issues are continued from 1st dose but extremely exacerbated now since the second dose. Daily headaches are more extreme requiring pain meds.
Janssen COVID-19 Vaccine EUA Felt light headed at 8pm. I laid down and then started to get terrible chills. Around 10pm the chills turned to muscle aches all over and a terrible headache. Had a fever of 99.9 at 3am.  The headache and mild muscle aches have continued into the next day as of 9:30am.  The site of injection has been sore to the touch ever since I got the shot as well.
2 mo infant rec'd DTP/OPV/HIBTITER on 6MAR91; Died 8MAR91; Reported as SIDS; Autopsy is being performed;pt found to have generalized viremia & viral myocarditis.Reporter states that death was not in any way related to immun.
pain lt arm rx excedrin;lightheaded w/blackout while marching in band;mom states eyes dilated, difficulty walking, legs like jerking-no strength;MD saw pt in ER;less lightheaded but memory unclear;weakness in legs;poss allergy;n/v
difficult swallowing post vaccine - tightness of throat. ;   Gave Epi 0.5ml at 14;18;   Ambulance at 1430
8 days after vaccination I broke out in hives. Everywhere besides my face I felt feverish the hives went down 30 mins after I took Benadryl.